Effects of αvβ6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells

Anticancer Research

Volumn 30, Issue 1, 2010, Pages 135-142

  Niu, Weibo ^a   Liu, Xiangqun ^a   Zhang, Zhaoyang ^a   Xu, Kesen ^a   Chen, Rong ^b   Liu, Enyu ^a   Wang, Jiayong ^a   Peng, Cheng ^a   Niu, Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Chemosensitivity; Integrin v 6; Invasion; Proliferation; RNA interference

Indexed keywords

ALPHAVBETA6 INTEGRIN; GEMCITABINE; SMALL INTERFERING RNA; ANTINEOPLASTIC ANTIMETABOLITE; CASPASE 3; DEOXYCYTIDINE; DRUG DERIVATIVE; INTEGRIN; MESSENGER RNA; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL CYCLE ARREST; CELL INVASION; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG INHIBITION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL; RNA INTERFERENCE; ADENOCARCINOMA; BIOSYNTHESIS; CELL CYCLE G2 PHASE; CELL DIVISION; CELL GROWTH; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CASPASE 3; CELL DIVISION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DEOXYCYTIDINE; G2 PHASE; GENE SILENCING; HUMANS; INTEGRINS; PANCREATIC NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 77649257846     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bardeesy N and DePinho RA: Pancreatic cancer biology and genetics. Nat Rev Cancer 2: 897-909, 2002.
2. Li D, Xie K, Wolff R and Abbruzzese JL: Pancreatic cancer. Lancet 363: 1049-1057, 2004.
3. Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H and Ungefroren H: Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. Int J Cancer 109: 182-188, 2004.
4. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002.
5. Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100, 2002.
6. Frisch SM and Ruoslahti E: Integrins and anoikis. Curr Opin Cell Biol 9: 701-706, 1997.
7. Thomas GJ, Nyström ML and Marshall JF: αvβ6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med 35: 1-10, 2006.
8. Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H, Sheppard D, Oettgen P and Mercurio AM: Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 115: 339-347, 2005.
9. Zhang ZY, Xu KS, Wang JS, Yang GY, Wang W, Wang JY, Niu WB, Liu EY, Mi YT and Niu J: Integrin αvβ6 acts as a prognostic indicator in gastric carcinoma. Clin Oncol 20: 61-66, 2008.
10. Niu J, Gu X, Turton J, Meldrum C, Howard EW and Agrez M: Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem Biophys Res Commun 249: 287-291, 1998.
11. Gu X, Niu J, Dorahy DJ, Scott R and Agrez MV: Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells. Br J Cancer 87: 348-351, 2002.
12. Zhao-Yang Z, Ke-Sen X, Qing-Si H, Wei-Bo N, Jia-Yong W, Yue-Tang M, Jin-Shen W, Guo-Qiang W, Guang-Yun Y and Jun N: Signaling and regulatory mechanisms of integrin αvβ6 on the apoptosis of colon cancer cells. Cancer Lett 266: 209-215, 2008.
13. Schiffelers RM, Woodle MC and Scaria P: Pharmaceutical prospects for RNA interference. Pharm Res 21: 1-7, 2004.
14. Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A and Malvy C: Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 296: 1000-1004, 2002.
15. Raitano AB, Scuderi P and Korc M: Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells. Pancreas 5: 267-277, 1990.
16. Arihiro K, Kaneko M, Fujii S, Inai K and Yokosaki Y: Significance of α9β1 and αvβ6 integrin expression in breast carcinoma. Breast Cancer 7: 19-26, 2000.
17. Ahmed N, Pansino F, Clyde R, Murthi P, Quinn MA, Rice GE, Agrez MV, Mok S and Baker MS: Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis 23: 237-244, 2002.
18. Sipos B, Hahn D, Carceller A, Piulats J, Hedderich J, Kalthoff H, Goodman SL, Kosmahl M and Klöppel G: Immunohistochemical screening for β6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology 45: 226-236, 2004.
19. Thomas GJ, Lewis MP, Hart IR, Marshall JF and Speight PM: αVβ6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 92: 641-650, 2001.
20. Yang GY, Xu KS, Pan ZQ, Zhang ZY, Mi YT, Wang JS, Chen R and Niu J: Integrin αvβ6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci 99: 879-887, 2008.
21. Ahmed N, Niu J, Dorahy DJ, Gu X, Andrews S, Meldrum CJ, Scott RJ, Baker MS, Macreadie IG and Agrez MV: Direct integrin αvβ6-ERK binding: implications for tumour growth. Oncogene 21: 1370-1380, 2002.
22. Hannon GJ: RNA interference. Nature 418: 244-251, 2002.
23. Cao Q, Cai W, Li T, Yang Y, Chen K, Xing L and Chen X: Combination of integrin siRNA and irradiation for breast cancer therapy. Biochem Biophys Res Commun 351: 726-732, 2006.
24. Wang J, Zhang Z, Xu K, Sun X, Yang G, Niu W, Liu E, Peng C, Lin P, Wang J, Chen R, Agrez M and Niu J: Suppression of integrin αvβ6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway. Int J Cancer 123: 1311-1317, 2008.